Screening compound: InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3

Screening compound: InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3
Screening compound: InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E213-0346

Molecular Formula

C17H21N3O2S (C17 H21 N3 O2 S)

Compound Name

3-methyl-2-(1-pyrrolidinylcarbonyl)-7,8,9,10-tetrahydrothieno[2',3':4,5]pyrimido[1,2-a]azepin-4(6H)-one

IUPAC name

4-methyl-5-(pyrrolidine-1-carbonyl)-6-thia-18-diazatricyclo[7.5.0.0^{37}]tetradeca-3(7)48-trien-2-one

SMILES

Cc1c(C(N2CCCC2)=O)sc(N=C2N3CCCCC2)c1C3=O

InChI

InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3

InChI Key

DWJWAFLBCXVHKF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14847097

InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Purinergic Library (3321 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • Kinases
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3?
Check Price and Availability of InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C17H21N3O2S/c1-11-13-15(23-14(11)17(22)19-8-5-6-9-19)18-12-7-3-2-4-10-20(12)16(13)21/h2-10H2,1H3 available by request